The aim of this paper is therefore to critically review the current literature surrounding the use of BPC 157, as a feasible therapy for healing and functional restoration of soft tissue damage, with a focus on tendon, ligament and skeletal muscle healing
During isolation and purification procedure was observed the appearance of more active fractions, the highest in the region at about 250 kDa (S-290), then at about 70 kDa, 40 kDa and even at 25 kDa
"Laser warning goes modular"
Beyond 48 hours, potency loss becomes measurable
READ the full study in RAPM: #PhantomLimbPain #Cryoneurolysis #PainMedicine #RegionalAnesthesia #ClinicalResearch #Innovation To view or add a comment, sign in Ophthopedia Update:Mitomycin C in Non-Endoscopic Endonasal Dacryocystorhinostomy: A Randomized Clinical Trial involving 442 cases: Mitomycin C (MMC) is used as an adjuvant in endonasal endoscopic dacryocystorhinostomy (EN-DCR) despite the existing heterogeneity in the literature on the concentration, duration of application, indication and outcomes
This neuroendocrine pathway is mechanistically distinct from the hypothalamic and gut-brain circuits predominantly engaged by GLP-1 receptor agonists
